Compass Therapeutics, Inc. (CMPX), a clinical-stage, oncology-focused biopharmaceutical company, on Monday announced that it has appointed Arjun Prasad as Chief Commercial Officer and Cynthia Sirard as Chief Medical Officer, effective as of January 1, 2026.
Cyndi brings more than two decades of experience in oncology drug development and previously served as Chief Medical Officer at Leap Therapeutics.
Before joining the company, Prasad was Chief Commercial Officer at Servier Pharmaceuticals.
In the pre-market trading, Compass Therapeutics is 6.19% higher at $5.49 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.